Comparison of methods for assessing synergic antibiotic interactions

International Journal of Antimicrobial Agents

Volumn 15, Issue 2, 2000, Pages 125-129

  MacKay, M L ^a   Milne, K ^a   Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antibiotic; Chequerboards; Synergic

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; RIFAMPICIN; TEMOCILLIN; TRIMETHOPRIM;

ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; COMBINATION CHEMOTHERAPY; DRUG POTENTIATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; STAPHYLOCOCCUS AUREUS;

BACTERIA; BURKHOLDERIA CEPACIA; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; STAPHYLOCOCCUS AUREUS; THIENAMYCINS;

EID: 0034081239     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00149-7     Document Type: Article

References (18)

1. Berenbaum M. Minor synergy and antagonism may be clinically important. J. Antimicrob. Chemother. 19:1987;271-280.
2. Yu V.I., Zuravleff J.J., Barnholm J., Archer G. In vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis. J. Antimicrob. Chemother. 14:1984;359-366.
3. Norden C. Comparison of techniques for measurements of an in vitro antibiotic synergism. J. Infect. Dis. 140:1979;629-633.
4. Reyes M.P., El-Khatib M.R., Brown W.J., Smith F., Lerner A.M. Synergy between carbenicillin and aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J. Infect. Dis. 140:1979;192-202.
5. Gould I.M., Wilson D., Milne K., Paterson A., Golder D., Russell D. Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques. Antimicrob. Agents Chemother. 35:1991;2407-2409.
6. Gould I.M., Milne K., Jason D. In vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. J. Antimicrob. Chemother. 39:1997;53-61.
7. Hodge S., Seed M. Statistics and Probability. 1972;184 Blackie and Chambers, Glasgow.
8. Lorian V, editor. Antibiotics in Laboratory Medicine. London: Williams and Wilkins, 1986 [chapter 5] pp. 537-595.
9. Rand R.H., Houck H.K., Brown P., Bennett D. Reproducibility of microdilution checkerboard method for antibiotic synergy. Antimicrob. Agents Chemother. 37:1993;613-615.
10. Horrevorts A.M., de Ridder C.M., Poot M.C., de Jonge M.J., Degener J.E., Dzoljic-Danilovic G. et al. Checkerboards titrations: the influence of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index. J. Antimicrob. Chemother. 19:1987;119-125.
11. Wootton M, Hedges AJ, Bowker KE, Holt HA, Reeves DS, MacGowan AP. A critical assessment of the agar dilution checkerboard technique for studying in-vitro antimicrobial interactions using a representative β-lactam, aminoglycoside and fluroquinolone, J Antimicrob Chemother 1995:569-576.
12. Owens R.C., Banevicius M.A., Nicolau D.P., Nightingale C.H., Quintiliani R. In vitro synergistic activities of tobramycin and selected β-lactams against 75 gram-negative clinical isolates. Antimicrob. Agents Chemother. 41:1997;2586-2588.
13. Di Pentima M.C., Mason E.O., Kaplan S.L. In vitro antibiotic synergy against Flavobacterium meningosepticum: Implications for therapeutic options. Clin. Infect. Dis. 26:1998;1169-1176.
14. Den Hollander J.G., Mouton J.W., Verbrugh H.A. Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics. Antimicrob. Agents Chemother. 42:1998;744-748.
15. White R.L., Burgess D.S., Manduru M., Bosso J.A. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. J. Clin. Microb. 40:1996;1914-1918.
16. Jarlier V., Nicolas M., Fournier G., Philippon A. Extended broad spectrum β lactamases conferring transerable resistance to newer β lactam agents in enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:1988;867-871.
17. Hobson R.P., MacKenzie F.M., Gould I.M. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J. Hosp. Infect. 33:1996;249-262.
18. Bustamante C.L., Wharton R.C., Wade J.C. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam and azlocillin against multiresistant isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34:1990;1814-1815.